Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01606826 · ClinicalTrials.gov registry record
Severe Asthma Research Program
A clinical trial of Asthma, sponsored by Milton S. Hershey Medical Center.
- Active
- Registry status
- 1,100
- Enrollment target
- 8
- Study locations
NCT01606826: Active study of Asthma, sponsored by Milton S. Hershey Medical Center.
NCT01606826 is a study of Asthma that is active but no longer recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 1,100 participants, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (29% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01606826, a study of Asthma, is active but no longer recruiting, sponsored by Milton S. Hershey Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 1,100 participants
- Enrollment target
- 8
- Study locations
Study Summary
The mission of the SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.
Primary Outcome
Pulmonary function test results include forced expiratory volume in one second (FEV1) and forced vital capacity (FVC).
Conditions Studied
Study Locations (8)
Massachusetts
- Brigham & Women's Hospital - Boston
- Children's Hospital, Boston - Boston
California
- University of California, San Francisco - San Francisco
Missouri
- Washington University - St Louis
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Ohio
- Cleveland Clinic - Cleveland
Pennsylvania
- University of Pittsburgh - Pittsburgh
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2012-10 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT01606826 still lists
NCT01606826 is an observational study that tracks outcomes without assigning an intervention. Its 1,100 participants enrollment target places it among the larger protocols in the corpus, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT01606826 lists 8 locations in 7 states (Massachusetts, California, Missouri).
Frequently Asked Questions
What is clinical trial NCT01606826 about?
NCT01606826 is a clinical study titled "Severe Asthma Research Program". The mission of the SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.
What is the current status of trial NCT01606826?
This trial is currently active not recruiting. The enrollment target is 1,100 participants. The study started on 2012-10. Estimated completion is 2026-12-31.
What conditions does trial NCT01606826 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT01606826?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01606826 being conducted?
This trial has 8 study locations across California, Massachusetts, Missouri, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01606826's enrollment target sits among peer trials
1,100 36th of 374 higher than 339 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia